Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCRESOL
Stock Latest News
Private Companies
Resolution Therapeutics Reaches Key Milestone in RTX001 EMERALD Trial
3d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Partners With Blood Centers of America on U.S. Cell Therapy Access
13d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Advances Regenerative Macrophage Therapy for Advanced Liver Disease
19d ago
RESOL
Premium
Private Companies
Experimental Cell Therapy for Advanced Liver Disease Draws Clinical Interest
26d ago
RESOL
Premium
Private Companies
Experimental Regenerative Liver Therapy RTX001 Progresses Through Phase 1/2 Trial
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Advances Regenerative Macrophage Therapy for Advanced Liver Disease
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Gains Policy Spotlight as RTX001 Advances and Macrophage Strategy Wins Scientific Backing
2M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlighted in R&D Campaign as RTX001 Enters Phase 1/2 Trial
2M ago
RESOL
Premium
Private Companies
Cell-Based Liver Therapy Review Underscores Resolution Therapeutics’ Regenerative Macrophage Strategy
2M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights RTX-001 and Commercial Focus at Cell and Gene Therapy Summit
2M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Advances RTX001 Trial and In Vivo Macrophage Platform in Active Week
3M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Regenerative Macrophage Therapy Pipeline Expansion
3M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Expands Regenerative Macrophage Platform With In Vivo LNP Program
3M ago
RESOL
Premium
Private Companies
Resolution Therapeutics – Weekly Recap
3M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Growing Fatty Liver Disease Burden and Progress of RTX001 Trial
3M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Regenerative Macrophage Therapy Pipeline and Conference Participation
3M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Builds Momentum as MATCH Data and EMERALD Trial Advance RTX001 Strategy
4M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Leadership to Attend Jefferies Global Healthcare Conference
4M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Leadership to Attend Jefferies Global Healthcare Conference
4M ago
RESOL
Premium
Private Companies
Regenerative Macrophage Therapy Candidate RTX001 Advances in Early-Stage Liver Disease Trial
4M ago
RESOL
Premium
Private Companies
Media Coverage and Clinical Progress Spotlight Resolution Therapeutics’ Liver Therapy Pipeline
4M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Clinical Progress in Regenerative Macrophage Therapy
4M ago
RESOL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
